Triglyceride Glucose Index as an Indicator of Cardiovascular Risk in Syrian Refugees

References

• Labarthe DR. Epidemiology and prevention of cardiovascular diseases, a global challenge, a global challenge; 2010.
   Google Scholar
• Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):1–14. doi:10.1186/s12933-018-0762-4
   PubMed Web of Science ®Google Scholar
• Hung AM, Sundell MB, Egbert P, et al. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(4):767. doi:10.2215/CJN.08070910
   PubMed Web of Science ®Google Scholar
• Jia T, Huang X, Qureshi AR, et al. Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. Kidney Int. 2014;86(2):383–391. doi:10.1038/ki.2014.1
   PubMed Web of Science ®Google Scholar
• Aronis KN, Mantzoros CS. A brief history of insulin resistance, from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways. Metabolism. 2012;61(4):445–449. doi:10.1016/j.metabol.2012.01.001
   PubMed Web of Science ®Google Scholar
• Laakso M. Is insulin resistance a feature of or a primary risk factor for cardiovascular disease? Curr Diab Rep. 2015;15(12):1–9. doi:10.1007/s11892-015-0684-4
   Web of Science ®Google Scholar
• Zhang S, Yin R-X, Gao H, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):1–8. doi:10.1186/s12944-016-0392-3
   PubMedGoogle Scholar
• Won K-B, Park EJ, Han D, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19(1):1–8. doi:10.1186/s12933-020-01008-5
   PubMed Web of Science ®Google Scholar
• Sánchez‐íñigo L, Navarro‐González D, Fernández‐Montero A, et al. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–197. doi:10.1111/eci.12583
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Irace C, Carallo C, Scavelli FB, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665–672. doi:10.1111/ijcp.12124
   PubMed Web of Science ®Google Scholar
• Vasques ACJ, Novaes FS, de Oliveira MDS, et al. TyG index performs better than HOMA in a Brazilian population, a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi:10.1016/j.diabres.2011.05.030
   PubMed Web of Science ®Google Scholar
• Nam K-W, Kwon H-M, Jeong H-Y, et al. High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population, a cross-sectional study. Cardiovasc Diabetol. 2020;19(1):1–8. doi:10.1186/s12933-020-01031-6
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia A, Rodríguez-Gutiérrez R, Mancillas-Adame L, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance, a systematic review. Int J Endocrinol. 2020;2020:1–7. doi:10.1155/2020/4678526
   Web of Science ®Google Scholar
• da Silva A, Caldas APS, Hermsdorff HHM, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18(1):1–8. doi:10.1186/s12933-019-0893-2
   PubMedGoogle Scholar
• Araújo SP, Juvanhol LL, Bressan J, Hermsdorff HH. Triglyceride glucose index, A new biomarker in predicting cardiovascular risk. Prev Med Rep. 2022;29:101941. doi:10.1016/j.pmedr.2022.101941
   PubMedGoogle Scholar
• Park G-M, Cho Y-R, Won K-B, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19(1):1–7. doi:10.1186/s12944-020-1187-0
   PubMed Web of Science ®Google Scholar
• Luo E, Wang D, Yan G, et al. High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):1–12. doi:10.1186/s12933-019-0957-3
   PubMed Web of Science ®Google Scholar
• Doocy S, Lyles E, Akhu-Zaheya L, et al. Health service access and utilization among Syrian refugees in Jordan. Int J Equity Health. 2016;15(1):1–15. doi:10.1186/s12939-016-0399-4
   PubMedGoogle Scholar
• UNHCR; 2022 [ cited January 11, 2023]. Available from: https://www.unrefugees.org/news/rebuilding-futures-how-unhcr-is-empowering-syrian-refugees-through-mental-health-support/#,~,text=In%20Syria%2C%20the%20prevalence%20of,to%20prolonged%20exposure%20to%20conflict. Accessed March 19, 2024.
   Google Scholar
• Hammad AM, Al Qerem W, Alaqabani H, Alasmari F, Ling J. Factors influencing hypertension and diabetes mellitus control among Syrian refugees in Zaatari refugee camp. Eur Rev Med Pharmacol Sci. 2022;26(7).
   Web of Science ®Google Scholar
• Ali N, Al Ganideh SF. Syrian refugees in Jordan, Burden or boon. Res World Econ. 2020;11(1):180–194. doi:10.5430/rwe.v11n1p180
   Google Scholar
• Dator W, Abunab H, Dao-Ayen N. Health challenges and access to health care among Syrian refugees in Jordan, a review. East Mediterr Health J. 2018;24(7):680–686. doi:10.26719/2018.24.7.680
   PubMed Web of Science ®Google Scholar
• Doocy S, Lyles E, Roberton T, et al. Prevalence and care-seeking for chronic diseases among Syrian refugees in Jordan. BMC Public Health. 2015;15(1):1–10. doi:10.1186/s12889-015-2429-3
   PubMedGoogle Scholar
• Ashcroft RE. The declaration of Helsinki. Oxford Textbook Clin Res Ethics. 2008;141–148.
   Google Scholar
• Schwartz GL, Sheps SG. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157(21):2413–2446. doi:10.1001/archinte.1997.00440420033005
   PubMedGoogle Scholar
• Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension, a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16(1):1–7. doi:10.1186/s12944-017-0562-y
   PubMedGoogle Scholar
• Anderson TJ, Grégoire J, Hegele RA, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Cana J Cardiol. 2013;29(2):151–167. doi:10.1016/j.cjca.2012.11.032
   PubMed Web of Science ®Google Scholar
• Sena CM, Carrilho F, Seiça RM. Endothelial dysfunction in type 2 diabetes, targeting inflammation. Endothelial Dysfunction. 2018;24:23110.
   Google Scholar
• Dwaib HS, AlZaim I, Eid AH, et al. Modulatory effect of intermittent fasting on adipose tissue inflammation, amelioration of cardiovascular dysfunction in early metabolic impairment. Front Pharmacol. 2021;12:626313. doi:10.3389/fphar.2021.626313
   PubMed Web of Science ®Google Scholar
• Luk C, Haywood NJ, Bridge KI, et al. Paracrine role of the endothelium in metabolic homeostasis in health and nutrient excess. Front Cardiovasc Med. 2022;9:882923. doi:10.3389/fcvm.2022.882923
   PubMed Web of Science ®Google Scholar
• Ertunc ME, Hotamisligil GS. Lipid signaling and lipotoxicity in metaflammation, indications for metabolic disease pathogenesis and treatment. J Lipid Res. 2016;57(12):2099–2114. doi:10.1194/jlr.R066514
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB, Perreault L, Ji L, et al. Diagnosis and management of prediabetes, a review. JAMA. 2023;329(14):1206–1216. doi:10.1001/jama.2023.4063
   PubMed Web of Science ®Google Scholar
• Kranenburg G, van der Graaf Y, van der Leeuw J, et al. The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease. Diabetes Care. 2015;38(10):1930–1936. doi:10.2337/dc15-0493
   PubMed Web of Science ®Google Scholar
• Zhao W, Katzmarzyk PT, Horswell R, et al. HbA1c and coronary heart disease risk among diabetic patients. Diabetes Care. 2014;37(2):428–435. doi:10.2337/dc13-1525
   PubMed Web of Science ®Google Scholar
• Cavalot F, Petrelli A, Traversa M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women, lessons from the san Luigi Gonzaga diabetes study. J Clin Endocrinol Metab. 2006;91(3):813–819. doi:10.1210/jc.2005-1005
   PubMed Web of Science ®Google Scholar